Manufacturing

Articles

The collaboration between the two companies aims to finish all necessary work needed to file for a first-in-human study by early 2019.

Helix BioPharma Partners with ProMab on CAR-T Therapies

The companies have partnered to develop and commercialize vectorized antibodies against tau for Alzheimer's and other neurodegenerative diseases.

AbbVie, Voyager Partner for New Alzheimer's Therapies

The companies have been awarded a collaborative grant of £1.9 million (US$2.6 million) from Innovate UK.

Cobra Biologics, Symbiosis Awarded Innovate UK Grant

Sean Milmo is a freelance writer based in Essex, UK.

Greater clarity and harmonization in ATMP regulations are needed to promote the development and commercialization of these therapies.

Barriers to ATMP Drug Development

GE Healthcare will equip Cellular Biomedicine Group's cell therapy manufacturing facility in Shanghai, China, with its FlexFactory single-use platform, designed to speed up cell therapy manufacturing timelines.

GE Healthcare to Equip Cell Therapy Manufacturing Facility with Single-Use Platform

The company is developing a pipeline of combination therapies using its patented polymer-based matrix delivery system, known as TAOS (targeted orchestrated signalling matrix).

Locate Therapeutics Achieves ISO 13845 Certification for Development and Control of Manufacturing for Resorbable Biomaterials

The companies aim to develop a potential zinc finger protein transcription factor-based gene therapy for treating Lou Gehrig’s disease.

Pfizer and Sangamo Partner on Gene Therapy for Lou Gehrig's Disease

The contract manufacturing company has completed construction on a new aseptic fill/finish facility in Wuxi, China.

Wuxi Griffin Opens a New Aseptic Fill Finish Facility

FDA has approved a new gene therapy for treating patients born with a rare, inherited vision loss.

FDA Approves Spark Therapeutics’ Gene Therapy for Inherited Vision Loss

The company has completed development of a first-generation production process for its chimeric antigen receptor regulatory T cell product portfolio and is selecting a CMO for clinical supply.

Manufacturing, Cell Therapies